// App-Quantinova.ai

9084 : Immune-related adverse events to predict survival in patients with advanced non-small cell lung cancer treated with nivolumab: A multicenter analysis.

Researchers

Presenter

  • Biagio Ricciuti

Principal Investigators

  • Andrea De Giglio

  • Marta Brambilla

  • Maria Bassanelli

  • Giulio Metro

  • Vienna Ludovini

  • Sara Baglivo

  • Rita Chiari

Medical Centers

  • Medical Oncology, Santa Maria della Misericordia Hospital, Perugia, Italy

  • Medical Oncology, Santa Maria della Misericordia Hospital, Perugia, Italy

  • Santa Maria della Misericordia Hospital, Perugia, Italy

  • Medical Oncology, Santa Maria della Misericordia Hospital, Perugia, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Nivolumab

Outcome

  • N/A

Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved